Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

作者: Scott Wolkenberg , Nathan R. Kett , Scott T. Harrison , Jeffrey Melamed , James C. Barrow

DOI:

关键词:

摘要: The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and useful in the treatment prevention neurological psychiatric disorders diseases COMT enzyme is involved. also pharmaceutical compositions comprising these use or such

参考文章(64)
Dong H Kim, Arthur A Santilli, 4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives ,(1973)
Marjatta Orama, Pirkko Tilus, Jyrki Taskinen, Timo Lotta, Iron(III)-Chelating Properties of the Novel Catechol O-Methyltransferase Inhibitor Entacapone in Aqueous Solution Journal of Pharmaceutical Sciences. ,vol. 86, pp. 827- 831 ,(1997) , 10.1021/JS960458S
Michael John Poirier, David Scott Edwards, Christopher Erik Ross Orvig, Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones ,(1991)
Lucius Kemp, John AstraZeneca Wilmington Mccauley, Marc AstraZeneca Wilmington Chapdelaine, N-type calcium channel antagonists for the treatment of pain ,(2001)
Virginia A. Sadock, Benjamin J. Sadock, Kaplan and Sadock's Comprehensive Textbook of Psychiatry ,(2017)
Laszlo Erno Kiss, Humberto Dos Santos Ferreira, Patricio Manuel Vieira Araújo Soares da Silva, David Alexander Learmonth, Pedro Nuno Leal Palma, Nitrocatechol derivatives as COMT inhibitors ,(2006)
Kevin J. Hodgetts, Dario Doller, 5-substituted 2-aryl-4-pyrimidinones ,(2001)